1. Home
  2. GPATU vs LSB Comparison

GPATU vs LSB Comparison

Compare GPATU & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPATU
  • LSB
  • Stock Information
  • Founded
  • GPATU N/A
  • LSB 2002
  • Country
  • GPATU
  • LSB China
  • Employees
  • GPATU N/A
  • LSB N/A
  • Industry
  • GPATU
  • LSB
  • Sector
  • GPATU
  • LSB
  • Exchange
  • GPATU NYSE
  • LSB NYSE
  • Market Cap
  • GPATU N/A
  • LSB 49.8M
  • IPO Year
  • GPATU N/A
  • LSB N/A
  • Fundamental
  • Price
  • GPATU $10.20
  • LSB $2.96
  • Analyst Decision
  • GPATU
  • LSB
  • Analyst Count
  • GPATU 0
  • LSB 0
  • Target Price
  • GPATU N/A
  • LSB N/A
  • AVG Volume (30 Days)
  • GPATU N/A
  • LSB 18.2K
  • Earning Date
  • GPATU N/A
  • LSB 01-21-2025
  • Dividend Yield
  • GPATU N/A
  • LSB N/A
  • EPS Growth
  • GPATU N/A
  • LSB N/A
  • EPS
  • GPATU N/A
  • LSB N/A
  • Revenue
  • GPATU N/A
  • LSB $79,415,311.00
  • Revenue This Year
  • GPATU N/A
  • LSB $39.33
  • Revenue Next Year
  • GPATU N/A
  • LSB $75.61
  • P/E Ratio
  • GPATU N/A
  • LSB N/A
  • Revenue Growth
  • GPATU N/A
  • LSB N/A
  • 52 Week Low
  • GPATU N/A
  • LSB $1.88
  • 52 Week High
  • GPATU N/A
  • LSB $11.20
  • Technical
  • Relative Strength Index (RSI)
  • GPATU N/A
  • LSB 55.32
  • Support Level
  • GPATU N/A
  • LSB $2.10
  • Resistance Level
  • GPATU N/A
  • LSB $2.77
  • Average True Range (ATR)
  • GPATU 0.00
  • LSB 0.37
  • MACD
  • GPATU 0.00
  • LSB 0.04
  • Stochastic Oscillator
  • GPATU 0.00
  • LSB 61.40

About GPATU GP-ACT III ACQUISITION CORP

GP-Act III Acquisition Corp is a blank check company.

About LSB LAKESHORE BIOPHARMA CO LTD

LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.

Share on Social Networks: